Creon 180000 [USP'U]/1

Creon 180000 [USP'U]/1 is a delayed-release pancreatic enzyme supplement designed to aid digestion. It contains pancrelipase, which helps break down fats, proteins, and carbohydrates. This medication is commonly used for individuals with exocrine pancreatic insufficiency.

Creon 180000 [USP'U]/1 is primarily used to manage digestive issues related to exocrine pancreatic insufficiency. This condition occurs when the pancreas does not produce enough enzymes to digest food properly. The pancrelipase in Creon helps to break down fats, proteins, and carbohydrates, making it easier for the body to absorb nutrients. It is often prescribed for individuals who have difficulty digesting food due to chronic pancreatitis, cystic fibrosis, or other pancreatic disorders.

Common effects of Creon 180000 [USP'U]/1 may include improved digestion and nutrient absorption. Some users might experience mild gastrointestinal discomfort, such as bloating or diarrhea, especially when starting the medication. These effects are generally temporary and should subside as the body adjusts to the enzyme supplementation.

Creon 180000 [USP'U]/1 should be taken as directed by a healthcare provider. It is important to swallow the capsules whole and not to crush or chew them, as this can affect their delayed-release mechanism. Keep the medication out of reach of children and store it at room temperature. Always follow the storage instructions provided with the medication.

Creon 180000 [USP'U]/1 may interact with certain medications, including antacids and other digestive enzymes. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Additionally, alcohol and certain foods may affect the effectiveness of the medication, so it is advisable to discuss dietary considerations with your healthcare provider.